Odontochondrodysplasia

Odontochondrodysplasia (ODCD), also known as dentinochondral dysplasia or Goldblatt syndrome, is an extremely rare genetic skeletal disorder characterized by the combination of severe dental abnormalities and skeletal dysplasia. The condition primarily affects the skeletal system and teeth, with features that become apparent in early childhood. Key clinical features include short stature, metaphyseal chondrodysplasia (abnormal cartilage and bone development at the growing ends of long bones), platyspondyly (flattened vertebral bodies), and significant dental anomalies including dentinogenesis imperfecta-like changes, delayed tooth eruption, abnormal tooth morphology, and early tooth loss. Additional skeletal findings may include brachydactyly (short fingers), joint laxity, and characteristic radiographic changes in the long bones and spine. The condition is caused by biallelic pathogenic variants in the TRIP11 gene, which encodes the Golgi-associated protein GMAP-210, important for intracellular protein trafficking and cartilage/bone development. Disruption of this protein leads to defective extracellular matrix secretion in chondrocytes and odontoblasts, explaining the combined skeletal and dental manifestations. There is currently no specific curative treatment for odontochondrodysplasia. Management is supportive and multidisciplinary, involving orthopedic care for skeletal complications, dental management for the significant tooth abnormalities, and monitoring of growth. Regular follow-up with clinical geneticists, orthopedic specialists, and dental professionals is recommended to address complications as they arise.

Common questions about Odontochondrodysplasia